Medicare will start the GLP-1 Bridge program July 1. Older adults who qualify for the weight-loss drugs will pay a monthly $50 copay.

Millions of Medicare enrollees will gain their first-ever coverage for drugs for weight loss under a temporary pilot program that launches July 1.

A new pilot program for adults with Medicare Part D coverage will cut the price of Wegovy, Zepbound, and Foundayo. Find out if you qualify.

Millions of people could meet criteria to receive GLP-1s, which could cost Medicare billions of dollars, according to a ...

The proportion of adults in the US taking GLP-1 medications for weight loss has reached a record high of about 40 million people.

The Trump administration will launch its pilot program on Wednesday. It lasts 18 months, and estimated costs to taxpayers have not been disclosed.

Insurance carriers need more proof that paying today’s GLP-1 drug prices will create “enough downstream savings,” assuming ...

Millions of Americans are expected to gain coverage for GLP-1 drugs for weight loss under a new U.S. pilot launching on ...

Starting this week, the federal government is offering a selection of the brand name medications to certain Medicare and Medicare Advantage beneficiaries for $50 a month through a new trial called ...

For the first time ever, Medicare will cover drugs like Wegovy and Zepbound. But a strict BMI checklist and a 2027 deadline have some experts expressing concern.

For the first time, Medicare will cover GLP-1 drugs prescribed solely for weight loss for eligible beneficiaries at a $50 monthly copay.

GLP-1 weight loss drugs just got a lot cheaper for many older Americans. Starting Wednesday, the federal government is offering a selection of the brand name medications to certain Medicare and ...